Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-06

Clinical Trial Update: Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A completed Phase 4 trial comparing olanzapine to aripiprazole for acutely ill patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole) (aripiprazole)
  • Zyprexa (Olanzapine) (Olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED